< Back to latest news & events

HGF Presents

Bioinformatics at the EPO

September 2025

Video overview:

What is Bioinformatics?

Bioinformatics involves the use of computational tools, software, algorithms, and AI to analyse biological data, such as genetic sequences, protein structures, or medical information.

Are Bioinformatics Inventions Patentable at the EPO?

Yes, bioinformatics inventions can be patented, but they must pass a two-hurdle approach:

The Two-Hurdle Approach

  • First Hurdle:
    • Question: Does the claimed invention fall within excluded subject matter categories?
    • How to satisfy: Typically overcome by adding a technical feature such as “computer-implemented method” or “a server configured to…”
    • Example: Claim a “computer-implemented method” for a bioinformatics algorithm.
  • Second Hurdle:
    • Question: Assessment of inventive step using the “problem-solution approach” for mixed-type inventions.
    • How to satisfy: Consider all features—both technical and non-technical—that contribute to a technical effect or purpose.
    • Example: Focus on the purpose of the invention and novel technical features that contribute to it.

Tips for Success

  • Bioinformatics AI inventions stand a better chance if they are applied to a specific field of technology, or are adapted to a particular technical implementation

 

Latest updates

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Read article

HGF Highly Ranked in Legal 500 2026

The Legal 500 UK 2026 rankings have been released and HGF has once again been ranked across several regions and practice areas. HGF continue to be ranked in the Top-Tier …

Read article